
The update adds efficacy and safety data on adults newly diagnosed with pulmonary arterial hypertension.
Transdermal fentanyl recalled by various manufacturers.
Actavis Inc. is recalling 14 lots of transdermal fentanyl due to a defect which may cause the patches to leak fentanyl gel outside the reservoir. No injuries have been reported; however, exposure to the gel could put patients and caregivers at risk for serious adverse events including respiratory depression and possible overdose. The affected Actavis





